Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Frontiers in bioengineering and biotechnology vol
GLP-1R agonists GLP-1R agonists exert GLP-1 activity and are resistant to DPP-4 degradation
You need treatments that can handle: High weekly mileage Year-round training Competitive goals Return to full performance The Cost of Delay Every month you wait, the damage gets worse
Published June 26 2025, 4:02 p.m
Liu, Q., Zhu, J., Kong, B., Shuai, W
Product Specifications Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum CAS Number: 2023788-19-2 Molecular Formula: CHNO Molecular Weight: 48 g/mol Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH Purity: 95% (verified by HPLC and mass spectrometry) Packaging Format: 30 mg lyophilized powder in a sealed research-grade vial Storage Conditions: Store 28 C (20 C long term)